Omnicell (OMCL) Competitors

HealthStream (NASDAQ:HSTM) and Omnicell (NASDAQ:OMCL) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations, community ranking and profitability.

Do analysts rate HSTM or OMCL?

HealthStream currently has a consensus target price of $32.00, indicating a potential downside of 0.07%. Omnicell has a consensus target price of $51.00, indicating a potential upside of 49.27%. Given Omnicell's higher possible upside, analysts plainly believe Omnicell is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthStream	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80
Omnicell	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Which has stronger valuation & earnings, HSTM or OMCL?

HealthStream has higher earnings, but lower revenue than Omnicell. HealthStream is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthStream	$291.65M	3.34	$15.21M	$0.66	48.52
Omnicell	$1.11B	1.44	$12.53M	$0.27	126.54

Does the MarketBeat Community prefer HSTM or OMCL?

Omnicell received 38 more outperform votes than HealthStream when rated by MarketBeat users. Likewise, 66.80% of users gave Omnicell an outperform vote while only 66.52% of users gave HealthStream an outperform vote.

Company	Underperform	Outperform
HealthStream	Outperform Votes 463 66.52%	Underperform Votes 233 33.48%
Omnicell	Outperform Votes 501 66.80%	Underperform Votes 249 33.20%

Do institutionals and insiders believe in HSTM or OMCL?

69.6% of HealthStream shares are held by institutional investors. Comparatively, 97.7% of Omnicell shares are held by institutional investors. 20.6% of HealthStream shares are held by insiders. Comparatively, 2.6% of Omnicell shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Is HSTM or OMCL more profitable?

HealthStream has a net margin of 6.84% compared to Omnicell's net margin of 1.13%. HealthStream's return on equity of 5.67% beat Omnicell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthStream	6.84%	5.67%	3.91%
Omnicell	1.13%	3.82%	2.07%

Which has more risk & volatility, HSTM or OMCL?

HealthStream has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500.

Does the media favor HSTM or OMCL?

In the previous week, Omnicell had 5 more articles in the media than HealthStream. MarketBeat recorded 8 mentions for Omnicell and 3 mentions for HealthStream. HealthStream's average media sentiment score of 1.73 beat Omnicell's score of 0.63 indicating that HealthStream is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthStream	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Omnicell	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

HealthStream beats Omnicell on 10 of the 18 factors compared between the two stocks.